This web site will not work properly without javascript!
RxDB
References
ICD-10-CM Codes
Browse (Tabular)
Diagnostic Codes Index
External Causes Index
Table of Neoplasms
Table of Drugs
ICD-10-PCS Codes
Browse (Tables)
ICD-9-CM Codes
ICD-9-PCS Codes
MDC / MS-DRG
HCPCS
Help
About RxDB
Sitemap
Contact Us
Terms of Service
Privacy Policy
ICD-10-CM Codes
Browse (Tabular)
Diagnostic
External
Drug
Neoplasm
T49.4X5A
–
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
Follow
Overview
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
GEM Conversion to ICD-9 CM
995.29
Fs:
10111
–
Unspecified adverse effect of other drug, medicinal and biological substance
E94.64
Fs:
10112
–
Keratolytics, keratoplastics, other hair treatment drugs and preparations causing adverse effects in therapeutic use
MDC / MS-DRG Reference
DRG 793
FULL TERM NEONATE WITH MAJOR PROBLEMS
DRG 917
POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC
DRG 918
POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC
Sibling Codes
T49.4X5D
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T49.4X5S
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
Parent Sibling Codes
T49.4X1
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional)
T49.4X2
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm
T49.4X3
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault
T49.4X4
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined
T49.4X5
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations
T49.4X6
Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations
Codes with Same Suffix
S06.4X5A
Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
T36.4X5A
Adverse effect of tetracyclines, initial encounter
T37.4X5A
Adverse effect of anthelminthics, initial encounter
T38.4X5A
Adverse effect of oral contraceptives, initial encounter
T39.4X5A
Adverse effect of antirheumatics, not elsewhere classified, initial encounter
T40.4X5A
Adverse effect of other synthetic narcotics, initial encounter
T42.4X5A
Adverse effect of benzodiazepines, initial encounter
T43.4X5A
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T44.4X5A
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T45.4X5A
Adverse effect of iron and its compounds, initial encounter
T46.4X5A
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T47.4X5A
Adverse effect of other laxatives, initial encounter
T48.4X5A
Adverse effect of expectorants, initial encounter
T50.4X5A
Adverse effect of drugs affecting uric acid metabolism, initial encounter
Loading ...